[1]
Sydorova, N.M. and Kolesnyk, M.Y. 2025. Choosing a class IC antiarrhythmic drug for the treatment of patients without structural heart disease: clinical advantages of the most common agents (literature review). Modern medical technology. 17, 3 (Sep. 2025), 199–204. DOI:https://doi.org/10.14739/mmt.2025.3.336359.